- September 27, 2019
- 8:30 AM - 5:00 PM ET
The U.S. Food and Drug Administration held a public meeting to discuss FDA’s effort to modernize standards of identity as part the agency's Nutrition Innovation Strategy.
Title: Horizontal Approaches to Food Standards of Identity Modernization
Date: September 27, 2019
Time: 8:30 a.m. until 5:00 p.m.
Location: Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852
In March 2018, the Commissioner of Food and Drugs announced a comprehensive, multi-year FDA Nutrition Innovation Strategy that is designed to improve healthy dietary behavior and help reduce preventable death and disease related to poor nutrition. The Nutrition Innovation Strategy focuses, among other things, on providing incentives for food manufacturers to produce products that have more healthful attributes. Under the Nutrition Innovation Strategy, FDA is seeking to modernize food standards of identity in a manner that will achieve three primary goals: (1) protect consumers against economic adulteration; (2) maintain the basic nature, essential characteristics, and nutritional integrity of food; and (3) promote industry innovation and provide flexibility to encourage manufacturers to produce more healthful foods.
The purpose of the public meeting is to give interested persons an opportunity to discuss FDA’s effort to modernize food standards of identity and provide information about changes we could make to existing standards, particularly changes that could be made across categories of standardized foods (i.e., horizontal changes), to facilitate innovation and provide flexibility for the development of healthier foods.
For more information about the meeting, see the Federal Register Notice announcing the meeting.
Remarks from the Meeting
- Remarks by Susan Mayne Ph. D., Director of the Center for Food Safety and Applied Nutrition
- Remarks by Rosalyn Murphy-Jenkins, Director of Labeling and Program Delivery Division, OPPD, FSIS, USDA
You may submit written/electronic comments starting August 29, 2019. Comments are due November 12, 2019. Submit comments electronically on https://www.regulations.gov/ to docket folder FDA-2018-N-2381. See the Federal Register Notice for additional information on commenting.